Clinical Trials Logo

Filter by:
NCT ID: NCT05446220 Recruiting - Obesity Clinical Trials

Twelve-year Follow-up on the Treatment of Obese Pregnant Women (TOP) Study

TOP12
Start date: January 5, 2023
Phase: N/A
Study type: Interventional

The participant (both mother and child) in the initial TOP study will be invited to a follow-up study to evaluate the effect of life style intervention during pregnancy on both mother and their offspring 12 years after the intervention. The study will contribute to understanding the transfer of obesity between generations and how to treat as well as prevent obesity.

NCT ID: NCT05445856 Recruiting - Postoperative Pain Clinical Trials

Intraoperative Methadone for Postoperative Pain in Patients Undergoing Tonsillectomy

METATONS
Start date: November 28, 2022
Phase: Phase 4
Study type: Interventional

A randomized controlled trial evaluating the efficacy and safety of single-shot intraoperative methadone for postoperative pain in patients undergoing tonsillectomy. Fentanyl is used as an active comparator

NCT ID: NCT05444348 Recruiting - Multiple Myeloma Clinical Trials

Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)

ACT
Start date: August 1, 2022
Phase: N/A
Study type: Interventional

Patients diagnosed with hematologic cancer are at substantial risk of dying, as 5-year survival among patients with acute myeloid leukemia is 20 % and only every second patient treated for incurable myeloma lives 5 years after date of diagnosis. Nevertheless, many overestimate their prognosis, and value of therapy. Patients with hematological cancers frequently have poor end of life outcomes, such as high treatment activity close to death, where clinical effects are doubtful, and low utilization of palliative care. Prognostic awareness and end of life (EOL) issues have urgency in the communication between patients, their caregiving relatives, and clinicians, in order to avoid futile treatments and suffering at EOL. Inspired by advanced care planning, the investigators developed the concept "Advance Consultations Concerning participants Life and Treatment" (ACT) in collaboration with a group consisting of hematologists, nurses, patients, and caregivers. The ACT concept consists of an 8-hour training day for clinicians, clinical tools, system changes, and preparation material for patients and caregivers prior to the consultation. ACT involves patients and caregivers earlier in preparation for life with chronic progressive disease and EOL-decisions, through an intervention based on compassionate communication and early planning of EOL-care. The aim of the study is to investigate the effect of the intervention on use of chemotherapy and quality of EOL-care in patients with hematological malignancy. Based on the results of the completed pilot study, the investigators are planning a nationwide 2-arm cluster randomized controlled trial where 40 physicians and 80 nurses across seven different hematological departments are randomized to either usual care or ACT training and completing ACT conversations. The investigators expect to include a total of 400 patients and their family caregivers. It is hypothesized that the ACT intervention will decrease use of futile chemotherapy, prepare patients and caregivers for difficult end-of-life-decisions, and improve quality of end-of-life care in hematology.

NCT ID: NCT05444101 Recruiting - Breast Cancer Clinical Trials

Optimizing Psychological Treatment for Pain After Breast Cancer

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The present study aims to optimize psychological treatment for pain after breast cancer by identifying active treatment components. Specifically, a factorial design will be used to evaluate the efficacy and change processes of three psychological treatment components, which have been shown to be efficacious in the treatment of pain after breast cancer.

NCT ID: NCT05443789 Recruiting - Clinical trials for Prescription Pattern

Academic Detailing About Proton Pump Inhibitors

BRIEF-PI
Start date: October 6, 2021
Phase: N/A
Study type: Interventional

General practices in the Capital Region of Denmark are offered a short educational visit and are randomized to either proton pump inhibitor (intervention) or another topic (control). The change in prescription pattern from before to after the visit is compared between the intervention and control group.

NCT ID: NCT05443308 Recruiting - Alzheimer Disease Clinical Trials

Cerebral Vascular Reserve in Small Vessel Disease and Alzheimers Disease

Start date: June 21, 2022
Phase:
Study type: Observational

Alzheimers disease and cerebral small vessel disease have a considerably overlap in patients and have common risk factors. The diseases are difficult to separate in individual patients and we hypothesize that a reduced cerebral vascular reserve may be a measurement of small vessel disease independent of Alzheimers disease. Patients with presumed Alzheimers disease (n=20), cerebral small vessel disease (n=20) and healthy age-matched subjects (n=15) are examined with quantitative [15O]H2O positron emission tomography (PET) for measurements of brain perfusion before and after diamox infusion that dilates cerebral vessels. Additional [15O]H2O PET scans of the heart allows for a non-invasive input function so the cerebral vascular reserve can be measured quantitatively.

NCT ID: NCT05442307 Recruiting - Clinical trials for Prescription Pattern

Academic Detailing About Asthma

BRIEF-A
Start date: October 6, 2021
Phase: N/A
Study type: Interventional

General practices in the Capital Region of Denmark are offered a short educational visit and are randomized to either asthma (intervention) or another topic (control). The change in prescription pattern from before to after the visit is compared between the intervention and control group.

NCT ID: NCT05440240 Recruiting - Neoplasms Clinical Trials

Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture

Start date: January 10, 2023
Phase: Phase 4
Study type: Interventional

Comparing percutaneous needle fasciotomy +/- corticosteroid injection for Dupuytren's contracture affecting metacarpophalangeal joints. A clinician-initiated, multicenter, randomized controlled trial.

NCT ID: NCT05439330 Recruiting - MRI Clinical Trials

Application of a Dental-dedicated MRI in the Diagnosis of Temporomandibular Joint Disorders, Tissue Alterations Related to Third Molars, Periapical and Periodontal Inflammatory Diseases, and Implant Treatment Planning

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The aim of the present study is to show that the use of 0.55T MRI combined with a "dental" coil produces images of sufficient diagnostic value to assess areas of interest in dentistry, and to compare MR images to traditional, dental-oriented radiographic images for diagnostic purposes.

NCT ID: NCT05438836 Recruiting - Anal Cancer Clinical Trials

Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer

ROAR-A
Start date: January 1, 2022
Phase:
Study type: Observational

A single-arm, prospective, Phase II, single-center clinical trial that will investigate if daily online adaptive radiotherapy for anal cancer will significantly reduce early treatment-related GI toxicity compared with the historically reported rate for non-adaptive intensity modulated radiation therapy (IMRT).